Compare AXGN & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXGN | REFI |
|---|---|---|
| Founded | N/A | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 255.6M |
| IPO Year | N/A | 2021 |
| Metric | AXGN | REFI |
|---|---|---|
| Price | $33.19 | $12.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $33.67 | $20.00 |
| AVG Volume (30 Days) | ★ 769.5K | 171.7K |
| Earning Date | 02-24-2026 | 11-04-2025 |
| Dividend Yield | N/A | ★ 17.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | ★ $214,709,000.00 | $54,287,847.00 |
| Revenue This Year | $21.60 | $13.78 |
| Revenue Next Year | $15.83 | $4.07 |
| P/E Ratio | ★ N/A | $7.07 |
| Revenue Growth | ★ 18.72 | N/A |
| 52 Week Low | $9.22 | $11.85 |
| 52 Week High | $34.24 | $16.27 |
| Indicator | AXGN | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 62.42 | 43.74 |
| Support Level | $30.32 | $11.89 |
| Resistance Level | $33.84 | $12.45 |
| Average True Range (ATR) | 1.49 | 0.27 |
| MACD | -0.26 | -0.09 |
| Stochastic Oscillator | 64.77 | 32.82 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.